This 5-month clinical trial is exploring whether an investigational medicine can help reduce symptoms in people aged 18 to 65 who are living with treatment-resistant depression (TRD).
This study is only being conducted at our Melbourne site.
Apply Now
TThis study is testing investigational mRNA vaccines targeting influenza (bird flu) to see how safe they are and how the immune system responds in healthy adults aged 18 to 49. Participants will receive the study vaccine by intramuscular injection and will be monitored through clinic visits, blood tests, and follow-up phone calls over about 7 months.
The study is being conducted at our Brisbane Clinic.
Paratus Clinical is proud to be a Society for Clinical Research Sites member. We actively participate in discussions and decisions that ultimately impact the industry at large. Being a part of the SCRS community gives us the opportunity to be heard and allows us to partake in industry training and events.
T: 1300 742 326
